Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study

This multicenter, prospective trial was conducted to develop an effective and safe reinduction regimen for marrow-relapsed pediatric acute lymphoblastic leukemia (ALL) by modifying the dose of idarubicin. Between 2006 and 2009, the trial accrued 44 patients, 1 to 21 years old with first marrow-relap...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Korean Med Sci
Hlavní autoři: Koh, Kyung-Nam, Im, Ho Joon, Kim, Hyery, Kang, Hyoung Jin, Park, Kyung Duk, Shin, Hee Young, Ahn, Hyo Seop, Lee, Ji Won, Yoo, Keon Hee, Sung, Ki Woong, Koo, Hong Hoe, Lim, Young Tak, Park, Jun Eun, Park, Byung-Kiu, Park, Hyeon Jin, Seo, Jong Jin
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Academy of Medical Sciences 2017
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5334163/
https://ncbi.nlm.nih.gov/pubmed/28244291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2017.32.4.642
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky